All In Biotech

Drug Trial Radar · NCT04513717

Two Studies for Patients With High Risk Prostate Cancer Testing Less Intense Treatment for Patients With a Low Gene Risk Score and Testing a More Intense Treatment for Patients With a High Gene Risk Score, The PREDICT-RT Trial

Parallel Phase III Randomized Trials for High Risk Prostate Cancer Evaluating De-Intensification for Lower Genomic Risk and Intensification of Concurrent Therapy for Higher Genomic Risk With Radiation (PREDICT-RT*)

Last checked: Nov 19, 2026Latest source record: Aug 17, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 2,753 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

2,753

Actual

Start

Jan 21, 2021

Primary completion

Dec 31, 2033

Study completion Dec 31, 2038

Sponsor

Lead sponsor
NRG OncologyAcademic, hospital or other
Sponsor type
Academic, hospital or other
Collaborators
National Cancer Institute (NCI)
First posted
Aug 14, 2020

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
None
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Male only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This phase III trial compares less intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in treating patients with high risk prostate cancer and low gene risk score. This trial also compares more intense hormone therapy and radiation therapy to usual hormone therapy and radiation therapy in patients with high risk prostate cancer and high gene risk score. Apalutamide may help fight prostate cancer by blocking the use of androgen by the tumor cells. Radiation therapy uses high energy rays to kill tumor cells and shrink tumors. Giving a shorter hormone therapy treatment may work the same at controlling prostate cancer compared to the usual 24 month hormone therapy treatment in patients with low gene risk score. Adding apalutamide to the usual treatment may increase the length of time without prostate cancer spreading as compared to the usual treatment in patients with high gene risk score.

Conditions

  • Prostate Adenocarcinoma
  • Stage III Prostate Cancer AJCC v8
  • Stage IVA Prostate Cancer AJCC v8

Interventions

  • ApalutamideDrug

    Given PO

  • BicalutamideDrug

    Given bicalutamide

  • Biospecimen CollectionProcedure

    Undergo blood sample collection

  • Bone ScanProcedure

    Undergo bone scan

  • BuserelinDrug

    Given buserelin

  • Computed TomographyProcedure

    Undergo CT scan

  • DegarelixDrug

    Given degarelix

  • FlutamideDrug

    Given flutamide

  • GoserelinDrug

    Given goserelin

  • HistrelinDrug

    Given histrelin

  • LeuprolideDrug

    Given leuprolide

  • Magnetic Resonance ElastographyProcedure

    Undergo MRI

  • Positron Emission TomographyProcedure

    Undergo PET scan

  • Quality-of-Life AssessmentOther

    Ancillary studies

  • Questionnaire AdministrationOther

    Ancillary studies

  • Radiation TherapyRadiation

    Undergo radiation therapy

  • RelugolixDrug

    Given relugolix

  • TriptorelinDrug

    Given triptorelin

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Metastasis-free survival (MFS)Time frame: From randomization to the date of detection of distant metastasis on standard imaging or date of death from any cause, assessed up to 13 years
  2. Sexual quality of life (De-intensification study)Time frame: Up to 13 years
  3. Hormonal quality of life (De-intensification study)Time frame: Up to 13 years
  4. Fatigue (Intensification study)Time frame: Up to 13 years

Locations

602 sites in 2 countries. Site status is shown where the registry gives one.

  • Fairbanks Memorial Hospital

    Fairbanks, Alaska

  • Banner MD Anderson Cancer Center

    Gilbert, Arizona

  • Arizona Center for Cancer Care - Gilbert

    Gilbert, Arizona

  • Arizona Center for Cancer Care-Peoria

    Peoria, Arizona

  • Arizona Center for Cancer Care - Phoenix

    Phoenix, Arizona

  • Arizona Center for Cancer Care - Scottsdale

    Scottsdale, Arizona

  • University of Arizona Cancer Center-North Campus

    Tucson, Arizona

  • University of Arkansas for Medical Sciences

    Little Rock, Arkansas

  • Sutter Cancer Centers Radiation Oncology Services-Auburn

    Auburn, California

  • AIS Cancer Center at San Joaquin Community Hospital

    Bakersfield, California

  • Alta Bates Summit Medical Center-Herrick Campus

    Berkeley, California

  • Sutter Cancer Centers Radiation Oncology Services-Cameron Park

    Cameron Park, California

  • Enloe Medical Center

    Chico, California

  • City of Hope Corona

    Corona, California

  • City of Hope Comprehensive Cancer Center

    Duarte, California

  • Kaiser Permanente Dublin

    Dublin, California

  • UC San Diego Health System - Encinitas

    Encinitas, California

  • Kaiser Permanente-Fremont

    Fremont, California

  • Palo Alto Medical Foundation-Fremont

    Fremont, California

  • Washington Hospital

    Fremont, California

  • Kaiser Permanente-Fresno

    Fresno, California

  • Marin General Hospital

    Greenbrae, California

  • UCI Health - Chao Family Comprehensive Cancer Center and Ambulatory Care

    Irvine, California

  • City of Hope at Irvine Lennar

    Irvine, California

  • UC San Diego Moores Cancer Center

    La Jolla, California

  • City of Hope Antelope Valley

    Lancaster, California

  • Los Angeles General Medical Center

    Los Angeles, California

  • USC / Norris Comprehensive Cancer Center

    Los Angeles, California

  • Cedars-Sinai Medical Center

    Los Angeles, California

  • Fremont - Rideout Cancer Center

    Marysville, California

  • Memorial Medical Center

    Modesto, California

  • Kaiser Permanente-Modesto

    Modesto, California

  • Providence Queen of The Valley

    Napa, California

  • Kaiser Permanente-Oakland

    Oakland, California

  • Saint Joseph Hospital - Orange

    Orange, California

  • UC Irvine Health/Chao Family Comprehensive Cancer Center

    Orange, California

  • Palo Alto Medical Foundation Health Care

    Palo Alto, California

  • Stanford Cancer Institute Palo Alto

    Palo Alto, California

  • Kaiser Permanente-Roseville

    Roseville, California

  • Sutter Cancer Centers Radiation Oncology Services-Roseville

    Roseville, California

Showing 40 of 602 sites, US sites first. The full list is on the registry record.

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.